About HandaPharma

This author has not yet filled in any details.
So far HandaPharma has created 26 blog entries.

Handa Pharmaceuticals Announces Tentative Approval of its First-to-File ANDA for AstraZeneca’s SEROQUEL XR®

December 13, 2010 Handa Pharmaceuticals, LLC ("Handa"), a specialty pharmaceutical company based in Fremont, California, today announced that the U.S. Food and Drug Administration ("FDA") has granted tentative approval of the Company's Abbreviated New Drug Application ("ANDA") for Quetiapine Fumarate Extended-Release Tablets, 50 mg., 150 mg., 200 mg., 300 mg., and 400 mg., a generic [...]

December 13th, 2010|News|

Handa Pharmaceuticals Announces Submission of its First-to-File ANDA for AstraZeneca’s SEROQUEL® XR

July 31, 2008 Handa Pharmaceuticals, LLC (“Handa”), a specialty pharmaceutical company based in Fremont, California, today confirmed that its Abbreviated New Drug Application (“ANDA”) for Quetiapine Fumarate Extended-Release Tablets, the generic version of AstraZeneca’s SEROQUEL® XR, has been accepted for filing by the U.S. Food and Drug Administration (“FDA”). Based upon available information, Handa believes [...]

July 31st, 2008|News|